Baidu
map

Hum Reprod Update:GnRH拮抗剂方案与激动剂长方案在IVF应用中的效果对比。

2017-08-03 qinqiyun MedSci原创

在一般IVF人群中,与激动剂长方案相比,GnRH拮抗剂处理的持续妊娠率更低,但OHSS发病率也更低。在该人群中,拮抗剂治疗可以预防每40个患者中一个OHSS,同时减少每28人中一例持续妊娠。GnRH激动剂长方案的标准疗法仍是治疗过早黄体化的选择。在PCOS和卵巢反应不佳的患者群体重,GnRH拮抗剂未见对持续妊娠率造成影响,又鉴于其可以降低OHSS的发病率,因此,可以考虑将GnRH拮抗剂作为标准治疗

背景:大多数对体外受精(IVF)卵巢刺激方案的综述都没有充分地考虑到诸如处于排卵期、多囊卵巢综合症(PCOS)患者或者卵巢反应不佳的女性群体,而且,在纳入的研究中,激动剂或拮抗剂并不是唯一的变量。

目的:本研究目的是将GnRH拮抗剂方案与标准的激动剂长方案在接受IVF或ICSI(卵泡浆内单精子注射)的人群中进行对比,并将多种患者人群和治疗疗程纳入考虑。

方法:研究人员将2016年6月前登记的对照试验和从PubMed、Embase数据库检索到的数据进行分类。纳入的是包含GnRH拮抗剂方案和标准GnRH激动剂长方案同时在接受IVF或ICSI的患者人群中进行的试验的文章。主要评估结局是持续妊娠率。次要评估结局是活产率、临床妊娠率和卵巢过度刺激综合征(OHSS)患者再取卵的数量和安全性。在一般的IVF人群、PCOS患者和卵巢反应不佳的患者中分开进行比较。对拮抗剂治疗不同疗程的患者进行预计划亚组分析。

结果:共纳入50个研究,其中34个是关于一般IVF患者,10个是关于PCOS患者,6个是关于卵巢反应不佳的患者。拮抗剂组的一般IVF患者持续妊娠率显着低于激动剂组(RR 0.89, 95% CI 0.82–0.96)。

对于PCOS患者和卵巢反应不佳患者,拮抗剂组和激动剂组之间在持续妊娠率上没有明显差异(RR分别是0.97, 95% CI 0.84–1.11、0.87, 95% CI 0.65–1.17)。

不同疗程的拮抗剂治疗的持续妊娠率明显比GnRH激动剂长方案,结合口服激素治疗药物(OHP)预处理时RR是0.74( 95% CI 0.59–0.91),未结合OHP时RR是0.84%(95% CI 0.71–1.0)。拮抗剂治疗疗程统一时,结合OHP或不结合,没有统计学差异(RR分别是0.94, 95% CI 0.79–1.12、0.94, 95% CI 0.83–1.05)。

在一般IVF和PCOS患者中,拮抗剂处理OHSS发病率明显更低(RR分别是0.63, 95% CI 0.50–0.81、 0.53, 95% CI 0.30–0.95)。

意义:在一般IVF人群中,与激动剂长方案相比,GnRH拮抗剂处理的持续妊娠率更低,但OHSS发病率也更低。在该人群中,拮抗剂治疗可以预防每40个患者中一个OHSS,同时减少每28人中一例持续妊娠。GnRH激动剂长方案的标准疗法仍是治疗过早黄体化的选择。在PCOS和卵巢反应不佳的患者群体重,GnRH拮抗剂未见对持续妊娠率造成影响,又鉴于其可以降低OHSS的发病率,因此,可以考虑将GnRH拮抗剂作为标准治疗方案。

原始出处:

C.B.Lambalk,F.r.Banga,et al.GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type.Hum Reprod Update.July 14,2017.https://doi.org/10.1093/humupd/dmx017.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1941655, encodeId=d2cc1941655d4, content=<a href='/topic/show?id=c2928150f3' target=_blank style='color:#2F92EE;'>#GnRH拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8150, encryptionId=c2928150f3, topicName=GnRH拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Nov 05 17:28:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796626, encodeId=065f1e966260c, content=<a href='/topic/show?id=6f28181514b' target=_blank style='color:#2F92EE;'>#Update#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18151, encryptionId=6f28181514b, topicName=Update)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Fri Dec 15 17:28:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763327, encodeId=ef311e63327eb, content=<a href='/topic/show?id=830281465d' target=_blank style='color:#2F92EE;'>#GnRH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8146, encryptionId=830281465d, topicName=GnRH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da137488682, createdName=夏天与十三菇凉, createdTime=Fri Nov 10 15:28:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310909, encodeId=98fe1310909c9, content=<a href='/topic/show?id=e1721013346' target=_blank style='color:#2F92EE;'>#IVF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10133, encryptionId=e1721013346, topicName=IVF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e5394, createdName=yeaweam, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511678, encodeId=afe615116e878, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56289, encryptionId=90d75628960, topicName=拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=474c10379153, createdName=ms5236388012055669, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601900, encodeId=6755160190016, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627744, encodeId=ef41162e74419, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66789, encryptionId=ab4f66e8913, topicName=激动剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95bc21134754, createdName=medscijoin, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1941655, encodeId=d2cc1941655d4, content=<a href='/topic/show?id=c2928150f3' target=_blank style='color:#2F92EE;'>#GnRH拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8150, encryptionId=c2928150f3, topicName=GnRH拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Nov 05 17:28:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796626, encodeId=065f1e966260c, content=<a href='/topic/show?id=6f28181514b' target=_blank style='color:#2F92EE;'>#Update#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18151, encryptionId=6f28181514b, topicName=Update)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Fri Dec 15 17:28:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763327, encodeId=ef311e63327eb, content=<a href='/topic/show?id=830281465d' target=_blank style='color:#2F92EE;'>#GnRH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8146, encryptionId=830281465d, topicName=GnRH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da137488682, createdName=夏天与十三菇凉, createdTime=Fri Nov 10 15:28:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310909, encodeId=98fe1310909c9, content=<a href='/topic/show?id=e1721013346' target=_blank style='color:#2F92EE;'>#IVF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10133, encryptionId=e1721013346, topicName=IVF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e5394, createdName=yeaweam, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511678, encodeId=afe615116e878, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56289, encryptionId=90d75628960, topicName=拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=474c10379153, createdName=ms5236388012055669, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601900, encodeId=6755160190016, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627744, encodeId=ef41162e74419, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66789, encryptionId=ab4f66e8913, topicName=激动剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95bc21134754, createdName=medscijoin, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1941655, encodeId=d2cc1941655d4, content=<a href='/topic/show?id=c2928150f3' target=_blank style='color:#2F92EE;'>#GnRH拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8150, encryptionId=c2928150f3, topicName=GnRH拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Nov 05 17:28:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796626, encodeId=065f1e966260c, content=<a href='/topic/show?id=6f28181514b' target=_blank style='color:#2F92EE;'>#Update#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18151, encryptionId=6f28181514b, topicName=Update)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Fri Dec 15 17:28:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763327, encodeId=ef311e63327eb, content=<a href='/topic/show?id=830281465d' target=_blank style='color:#2F92EE;'>#GnRH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8146, encryptionId=830281465d, topicName=GnRH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da137488682, createdName=夏天与十三菇凉, createdTime=Fri Nov 10 15:28:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310909, encodeId=98fe1310909c9, content=<a href='/topic/show?id=e1721013346' target=_blank style='color:#2F92EE;'>#IVF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10133, encryptionId=e1721013346, topicName=IVF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e5394, createdName=yeaweam, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511678, encodeId=afe615116e878, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56289, encryptionId=90d75628960, topicName=拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=474c10379153, createdName=ms5236388012055669, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601900, encodeId=6755160190016, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627744, encodeId=ef41162e74419, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66789, encryptionId=ab4f66e8913, topicName=激动剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95bc21134754, createdName=medscijoin, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1941655, encodeId=d2cc1941655d4, content=<a href='/topic/show?id=c2928150f3' target=_blank style='color:#2F92EE;'>#GnRH拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8150, encryptionId=c2928150f3, topicName=GnRH拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Nov 05 17:28:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796626, encodeId=065f1e966260c, content=<a href='/topic/show?id=6f28181514b' target=_blank style='color:#2F92EE;'>#Update#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18151, encryptionId=6f28181514b, topicName=Update)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Fri Dec 15 17:28:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763327, encodeId=ef311e63327eb, content=<a href='/topic/show?id=830281465d' target=_blank style='color:#2F92EE;'>#GnRH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8146, encryptionId=830281465d, topicName=GnRH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da137488682, createdName=夏天与十三菇凉, createdTime=Fri Nov 10 15:28:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310909, encodeId=98fe1310909c9, content=<a href='/topic/show?id=e1721013346' target=_blank style='color:#2F92EE;'>#IVF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10133, encryptionId=e1721013346, topicName=IVF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e5394, createdName=yeaweam, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511678, encodeId=afe615116e878, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56289, encryptionId=90d75628960, topicName=拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=474c10379153, createdName=ms5236388012055669, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601900, encodeId=6755160190016, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627744, encodeId=ef41162e74419, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66789, encryptionId=ab4f66e8913, topicName=激动剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95bc21134754, createdName=medscijoin, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=)]
    2017-08-05 yeaweam
  5. [GetPortalCommentsPageByObjectIdResponse(id=1941655, encodeId=d2cc1941655d4, content=<a href='/topic/show?id=c2928150f3' target=_blank style='color:#2F92EE;'>#GnRH拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8150, encryptionId=c2928150f3, topicName=GnRH拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Nov 05 17:28:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796626, encodeId=065f1e966260c, content=<a href='/topic/show?id=6f28181514b' target=_blank style='color:#2F92EE;'>#Update#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18151, encryptionId=6f28181514b, topicName=Update)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Fri Dec 15 17:28:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763327, encodeId=ef311e63327eb, content=<a href='/topic/show?id=830281465d' target=_blank style='color:#2F92EE;'>#GnRH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8146, encryptionId=830281465d, topicName=GnRH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da137488682, createdName=夏天与十三菇凉, createdTime=Fri Nov 10 15:28:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310909, encodeId=98fe1310909c9, content=<a href='/topic/show?id=e1721013346' target=_blank style='color:#2F92EE;'>#IVF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10133, encryptionId=e1721013346, topicName=IVF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e5394, createdName=yeaweam, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511678, encodeId=afe615116e878, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56289, encryptionId=90d75628960, topicName=拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=474c10379153, createdName=ms5236388012055669, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601900, encodeId=6755160190016, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627744, encodeId=ef41162e74419, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66789, encryptionId=ab4f66e8913, topicName=激动剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95bc21134754, createdName=medscijoin, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1941655, encodeId=d2cc1941655d4, content=<a href='/topic/show?id=c2928150f3' target=_blank style='color:#2F92EE;'>#GnRH拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8150, encryptionId=c2928150f3, topicName=GnRH拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Nov 05 17:28:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796626, encodeId=065f1e966260c, content=<a href='/topic/show?id=6f28181514b' target=_blank style='color:#2F92EE;'>#Update#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18151, encryptionId=6f28181514b, topicName=Update)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Fri Dec 15 17:28:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763327, encodeId=ef311e63327eb, content=<a href='/topic/show?id=830281465d' target=_blank style='color:#2F92EE;'>#GnRH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8146, encryptionId=830281465d, topicName=GnRH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da137488682, createdName=夏天与十三菇凉, createdTime=Fri Nov 10 15:28:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310909, encodeId=98fe1310909c9, content=<a href='/topic/show?id=e1721013346' target=_blank style='color:#2F92EE;'>#IVF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10133, encryptionId=e1721013346, topicName=IVF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e5394, createdName=yeaweam, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511678, encodeId=afe615116e878, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56289, encryptionId=90d75628960, topicName=拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=474c10379153, createdName=ms5236388012055669, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601900, encodeId=6755160190016, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627744, encodeId=ef41162e74419, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66789, encryptionId=ab4f66e8913, topicName=激动剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95bc21134754, createdName=medscijoin, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=)]
    2017-08-05 sunylz
  7. [GetPortalCommentsPageByObjectIdResponse(id=1941655, encodeId=d2cc1941655d4, content=<a href='/topic/show?id=c2928150f3' target=_blank style='color:#2F92EE;'>#GnRH拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8150, encryptionId=c2928150f3, topicName=GnRH拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Nov 05 17:28:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796626, encodeId=065f1e966260c, content=<a href='/topic/show?id=6f28181514b' target=_blank style='color:#2F92EE;'>#Update#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18151, encryptionId=6f28181514b, topicName=Update)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Fri Dec 15 17:28:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763327, encodeId=ef311e63327eb, content=<a href='/topic/show?id=830281465d' target=_blank style='color:#2F92EE;'>#GnRH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8146, encryptionId=830281465d, topicName=GnRH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da137488682, createdName=夏天与十三菇凉, createdTime=Fri Nov 10 15:28:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310909, encodeId=98fe1310909c9, content=<a href='/topic/show?id=e1721013346' target=_blank style='color:#2F92EE;'>#IVF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10133, encryptionId=e1721013346, topicName=IVF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e5394, createdName=yeaweam, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511678, encodeId=afe615116e878, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56289, encryptionId=90d75628960, topicName=拮抗剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=474c10379153, createdName=ms5236388012055669, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601900, encodeId=6755160190016, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627744, encodeId=ef41162e74419, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66789, encryptionId=ab4f66e8913, topicName=激动剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95bc21134754, createdName=medscijoin, createdTime=Sat Aug 05 00:28:00 CST 2017, time=2017-08-05, status=1, ipAttribution=)]

相关资讯

Hum Reprod:GnRH拮抗剂vs.GnRH激动剂,哪种发生OHSS的风险更低呢?

卵巢过度刺激综合征(OHSS)是体外受精(IVF)潜在的,最严重的致命的并发症。有些患者会表现为恶心、呕吐、腹胀,腹部疼痛。除此之外,OHSS可导致腹水和血液浓缩,使尿量减少,卵巢增大,出现多囊。在更严重的病例中,可能会导致胸水,心包积液,呼吸困难和循环系统问题。 尚无治疗OHSS的办法;最终只能依靠患者自行恢复,可提供支持治疗直到症状缓解。OHSS有几个确定的危险因素,最好的“治疗”方法就

Baidu
map
Baidu
map
Baidu
map